(Q38374699)

2 September 2017

title

A randomized controlled trial of ganaxolone in posttraumatic stress disorder (English)

1 reference

post-traumatic stress disorder

2 September 2017

main subject

1 reference

1

Ann M Rasmusson

1 reference

2 September 2017

Christine E Marx

2

1 reference

2 September 2017

Sonia Jain

3

1 reference

2 September 2017

Gail M Farfel

4

1 reference

2 September 2017

Julia Tsai

5

1 reference

2 September 2017

Xiaoying Sun

6

1 reference

2 September 2017

Thomas D Geracioti

7

1 reference

2 September 2017

Mark B Hamner

8

1 reference

2 September 2017

James Lohr

9

1 reference

2 September 2017

Richard Rosse

10

1 reference

2 September 2017

Lanier Summerall

11

1 reference

2 September 2017

Jennifer C Naylor

12

1 reference

2 September 2017

Cristine Cusin

13

1 reference

2 September 2017

Ariel J Lang

14

1 reference

2 September 2017

Rema Raman

15

1 reference

2 September 2017

Murray B Stein

16

1 reference

2 September 2017

publication date

1 July 2017

1 reference

2 September 2017

number of pages

13

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

2 September 2017

volume

234

1 reference

2 September 2017

issue

15

1 reference

2 September 2017

page(s)

2245-2257

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-017-4649-y

2 September 2017

exact match

0 references

cites work

Validation of the Insomnia Severity Index as an outcome measure for insomnia research.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

Psychopharmacological strategies in the management of posttraumatic stress disorder (PTSD): what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference (EILAT X).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

The development of a Clinician-Administered PTSD Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

A second look at comorbidity in victims of trauma: the posttraumatic stress disorder-major depression connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

Evaluation of performance of some enrichment designs dealing with high placebo response in psychiatric clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

Regulation of gephyrin and GABAA receptor binding within the amygdala after fear acquisition and extinction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

The PTSD Checklist-Civilian Version: reliability, validity, and factor structure in a nonclinical sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

Interim analysis: the alpha spending function approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

Considering future pharmacotherapy for PTSD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

Trial designs advance to overcome bitter pill of placebo effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

The PHQ-9: validity of a brief depression severity measure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

Assessment of ganaxolone's anticonvulsant activity using a randomized, double-blind, presurgical trial design. Ganaxolone Presurgical Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

Initial human experience with ganaxolone, a neuroactive steroid with antiepileptic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

Decreased corticolimbic allopregnanolone expression during social isolation enhances contextual fear: A model relevant for posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

Ganaxolone improves behavioral deficits in a mouse model of post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

Biological studies of post-traumatic stress disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

Decreased cerebrospinal fluid allopregnanolone levels in women with posttraumatic stress disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

Effects of antidepressant treatment on neuroactive steroids in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

The role of allopregnanolone in depression and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

Tonically active GABA A receptors: modulating gain and maintaining the tone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

Allopregnanolone elevations following pregnenolone administration are associated with enhanced activation of emotion regulation neurocircuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

Pharmacokinetic and behavioral effects of allopregnanolone in healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

Effects of allopregnanolone on sedation in men, and in women on oral contraceptives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

Anxiolytic-like effects of YL-IPA08, a potent ligand for the translocator protein (18 kDa) in animal models of post-traumatic stress disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

Two-Stage Experimental Designs: Early Stopping with a Negative Result

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-017-4649-Y

PXR (NR1I2): splice variants in human tissues, including brain, and identification of neurosteroids and nicotine as PXR activators

21 January 2018

1 reference

12 December 2020

Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial

1 reference

12 December 2020

Resolution of trauma-related guilt following treatment of PTSD in female rape victims: a result of cognitive processing therapy targeting comorbid depression?

1 reference

12 December 2020

Initial reliability and validity of a new retrospective measure of child abuse and neglect

1 reference

12 December 2020

Anticonvulsant activity of progesterone and neurosteroids in progesterone receptor knockout mice.

1 reference

12 December 2020

Diversity of inhibitory neurotransmission through GABA(A) receptors

1 reference

12 December 2020

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

1 reference

12 December 2020

Development and preliminary validation of a brief broad-spectrum measure of trauma exposure: the Traumatic Life Events Questionnaire

1 reference

12 December 2020

Psychometric properties of the life events checklist

1 reference

12 December 2020

Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting.

1 reference

12 December 2020

Neurosteroid modulation of GABAA receptors

1 reference

12 December 2020

10.1007/S00213-017-4649-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

1090313932

0 references

1 reference